Elekta

Board/Management Information • Nov 1, 2024

Caroline Leksell Cooke steps down from Elekta's Board of Directors

STOCKHOLM – Elekta AB (EKTA-B.ST) announces that Caroline Leksell Cooke will step down from her role on the Board of Directors, effective today, November 1, 2024. This follows the earlier announcement that Caroline Leksell Cooke will assume the role of Senior Vice President and Head of Neuro Solutions, effective the same date, and in connection therewith leave her position as a board member.

#

For further information, please contact:

Mattias Thorsson, Vice President, Head of Corporate Communications Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com Time zone: CET: Central European Time

About Elekta

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on "X", formerly known as Twitter.